O'Brien Greene & Co’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.93M Buy
131,555
+5,192
+4% +$370K 2.81% 14
2025
Q4
$7.8M Buy
126,363
+2,511
+2% +$148K 2.32% 18
2025
Q3
$7.27M Sell
123,852
-2,953
-2% -$172K 2.24% 18
2025
Q2
$7.39M Sell
126,805
-3,696
-3% -$209K 2.42% 17
2025
Q1
$6.48M Sell
130,501
-241
-0.2% -$12.3K 2.17% 18
2024
Q4
$5.85M Sell
130,742
-1,800
-1% -$85.5K 1.9% 22
2024
Q3
$6.37M Sell
132,542
-8,419
-6% -$406K 1.98% 24
2024
Q2
$7.18M Buy
140,961
+9,675
+7% +$530K 2.27% 17
2024
Q1
$7.13M Buy
131,286
+2,412
+2% +$126K 2.34% 16
2023
Q4
$7.26M Sell
128,874
-383
-0.3% -$21.6K 2.55% 10
2023
Q3
$7.98M Sell
129,257
-5,204
-4% -$329K 2.92% 6
2023
Q2
$7.94M Sell
134,461
-4,916
-4% -$313K 2.76% 9
2023
Q1
$10.3M Sell
139,377
-3,417
-2% -$264K 3.86% 5
2022
Q4
$10.4M Sell
142,794
-300,729
-68% -$23.8M 3.95% 2
2022
Q3
$37M Buy
443,523
+297,721
+204% +$25.6M 4.9% 1
2022
Q2
$11.6M Buy
145,802
+262
+0.2% +$25.4K 4.39% 1
2022
Q1
$15.1M Buy
145,540
+1,133
+0.8% +$93.9K 5% 1
2021
Q4
$10.9M Sell
144,407
-729
-0.5% -$51K 3.57% 3
2021
Q3
$9.41M Buy
145,136
+1,446
+1% +$88.4K 3.43% 3
2021
Q2
$8.71M Buy
143,690
+1,054
+0.7% +$62.4K 3.11% 3
2021
Q1
$7.69M Buy
142,636
+8,619
+6% +$469K 3.05% 3
2020
Q4
$6.45M Buy
134,017
+8,927
+7% +$395K 2.66% 7
2020
Q3
$4.91M Buy
125,090
+2,225
+2% +$81K 2.33% 14
2020
Q2
$3.94M Buy
122,865
+42,755
+53% +$1.49M 2.09% 20
2020
Q1
$2.72M Buy
80,110
+2,835
+4% +$113K 1.81% 23
2019
Q4
$3.7M Sell
77,275
-1,040
-1% -$50.3K 1.88% 21
2019
Q3
$3.91M Buy
78,315
+1,810
+2% +$92.4K 2.1% 17
2019
Q2
$4.09M Buy
76,505
+3,200
+4% +$167K 2.14% 15
2019
Q1
$3.87M Buy
73,305
+2,415
+3% +$126K 1.95% 20
2018
Q4
$3.33M Buy
+70,890
New +$3.7M 1.99% 19

Other funds holding NTR

O'Brien Greene & Co's NTR Position: Q1 2026 in Review

O'Brien Greene & Co increased its Nutrien (NTR) stake by 4.1% in Q1 2026, buying an estimated $370K and bringing the position to 131,555 shares worth $9.93M. The position accounts for 2.81% of the portfolio, ranked #14.

O'Brien Greene & Co first reported a position in NTR in Q4 2018 and has held it in 30 quarters since. The position peaked at $37M in Q3 2022. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • O'Brien Greene & Co held 131,555 shares of Nutrien worth $9.93M as of Q1 2026.
  • O'Brien Greene & Co bought 5,192 Nutrien shares in Q1 2026, an estimated $370K.
  • Nutrien made up 2.81% of O'Brien Greene & Co's portfolio in Q1 2026, its #14 holding.
  • O'Brien Greene & Co first reported a position in Nutrien in Q4 2018 and has held it in 30 quarters since.
  • O'Brien Greene & Co's Nutrien position peaked at $37M in Q3 2022.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on O'Brien Greene & Co's 13F filing for Q1 2026, filed 6 May 2026.